ArticleeLife2025

Targeting SLC7A11-mediated cysteine metabolism for the treatment of trastuzumab-resistant HER2-positive breast cancer.

Yijia Hua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.